Compare MLAB & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLAB | YDES |
|---|---|---|
| Founded | 1982 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.0M | 543.0M |
| IPO Year | 1995 | N/A |
| Metric | MLAB | YDES |
|---|---|---|
| Price | $107.00 | $4.37 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $94.00 | N/A |
| AVG Volume (30 Days) | ★ 114.9K | 4.8K |
| Earning Date | 05-27-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.67% | N/A |
| EPS Growth | ★ 99.24 | N/A |
| EPS | ★ 1.95 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | $54.92 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $59.63 | $4.37 |
| 52 Week High | $111.29 | $25.00 |
| Indicator | MLAB | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 31.36 |
| Support Level | $94.01 | N/A |
| Resistance Level | $107.88 | $5.36 |
| Average True Range (ATR) | 5.12 | 0.25 |
| MACD | 0.19 | -0.00 |
| Stochastic Oscillator | 70.61 | 0.03 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.